Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma
about
Controversies and evidence of hepatic resection for hepatocellular carcinomaTumor stage and primary treatment of hepatocellular carcinoma at a large tertiary hospital in China: A real-world study.The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma.Longitudinal alterations in health-related quality of life and its impact on the clinical course of patients with advanced hepatocellular carcinoma receiving sorafenib treatmentReport from European Association for the Study of the Liver: HCC Summit, Geneva, Switzerland, 2-5 February 2017.Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer.Genetic variants of cell cycle pathway genes predict disease-free survival of hepatocellular carcinomaAdvances and Future Directions in the Treatment of Hepatocellular CarcinomaDevelopment and validation of a risk prediction model for end-stage renal disease in patients with type 2 diabetes.Clinical significance of CMTM4 expression in hepatocellular carcinoma.Single nucleotide polymorphisms in MLH1 predict poor prognosis of hepatocellular carcinoma in a Chinese population.Staging and Prognostic Models for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.Editorial: rifaximin in cirrhosis-is this what we've been waiting for? Authors' reply.Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma.A Comparison of Staging Systems for Hepatocellular Carcinoma in a Multicenter US Cohort.Prognostic role of ABO blood group in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization.C-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors.
P2860
Q28072742-4EF17FD7-C02C-4B21-BF77-7B36323E26D6Q33566921-20EDBC6A-825A-4F78-913C-862E05A3EFF9Q35999601-7FE75D44-E2B5-4B11-8730-1C3CC7A67B77Q36190152-F793F35E-3BCA-4062-B552-AA45A11F9C6AQ38673823-27EE85CC-D5DC-47FD-A681-9B8224A5A38BQ38707454-5BFF7C1A-12C2-40F3-A6B6-206AA8F57373Q38714300-2E9493FA-ECEE-4A7E-B350-02EC5A959D46Q41531360-E362780C-1060-42D9-AD90-74C30A02C6B8Q41580258-FC434C4B-33E4-4370-9546-2E500160BDECQ45067272-C3521D79-97FD-4167-96D0-7F52EEA6C57CQ47141489-6C4FDA3F-A052-4F34-8E54-0B1B9885580AQ47915968-B466DABD-520B-43B4-ADC3-E32435EC291EQ48156251-A7A6346B-967A-439A-9240-982992D69E2BQ49164405-62399908-01B5-4737-8BCE-7C2713132C2AQ49507605-3C75455D-0E34-49C3-B49D-A0FFA373DD2BQ55000620-E81F1617-4C02-4E39-A706-5A8E0F068BB7Q55322477-3D1A68A8-79DA-4F46-B313-AAE2BA85783E
P2860
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Development and Validation of ...... with Hepatocellular Carcinoma
@ast
Development and Validation of ...... with Hepatocellular Carcinoma
@en
Development and Validation of ...... with Hepatocellular Carcinoma
@nl
type
label
Development and Validation of ...... with Hepatocellular Carcinoma
@ast
Development and Validation of ...... with Hepatocellular Carcinoma
@en
Development and Validation of ...... with Hepatocellular Carcinoma
@nl
prefLabel
Development and Validation of ...... with Hepatocellular Carcinoma
@ast
Development and Validation of ...... with Hepatocellular Carcinoma
@en
Development and Validation of ...... with Hepatocellular Carcinoma
@nl
P2093
P2860
P50
P3181
P1433
P1476
Development and Validation of ...... with Hepatocellular Carcinoma
@en
P2093
Alessandro Vitale
Anna Chiara Frigo
Anna Giacomin
Antonio Gasbarrini
Elisabetta Biasini
Eugenio Caturelli
Filomena Morisco
Francesca Ciccarese
Francesco Giuseppe Foschi
Franco Borzio
P2860
P304
P3181
P356
10.1371/JOURNAL.PMED.1002006
P407
P50
P577
2016-04-01T00:00:00Z